ResearcherCapital Medical UniversityActive in the last 2 years

Min-Fu Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9015-0541; OpenAlex author ID A5003953617, A5131327520. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Predicting overall survival in pancreatic ductal adenocarcinoma using 18F-FDG PET/CT radiomics: a two-center study. Last author DOI 10.1186/s13550-026-01399-8 ↗
Radiomics-based histological grading of pancreatic ductal adenocarcinoma using 18F-FDG PET/CT: A two-center study. Last author DOI 10.1016/j.ejrad.2025.112070 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yang Xu · 1 shared paper, 2026 · strength 0.33
- Paper Predicting overall survival in pancreatic ductal adenocarcinoma using 18F-FDG PET/CT radiomics: a two-center study. DOI 10.1186/s13550-026-01399-8 ↗
Xu Yang · 1 shared paper, 2025 · strength 0.28
- Paper Radiomics-based histological grading of pancreatic ductal adenocarcinoma using 18F-FDG PET/CT: A two-center study. DOI 10.1016/j.ejrad.2025.112070 ↗
Ren Lang · 1 shared paper, 2025 · strength 0.28
- Paper Radiomics-based histological grading of pancreatic ductal adenocarcinoma using 18F-FDG PET/CT: A two-center study. DOI 10.1016/j.ejrad.2025.112070 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.